Baxter International Inc. (BAX): Today's Featured Health Services Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Baxter International ( BAX) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day up 0.1%. By the end of trading, Baxter International fell $1.69 (-2.6%) to $63.89 on heavy volume. Throughout the day, 8,308,521 shares of Baxter International exchanged hands as compared to its average daily volume of 2,592,500 shares. The stock ranged in price between $62.80-$64.94 after having opened the day at $64.89 as compared to the previous trading day's close of $65.58. Other companies within the Health Services industry that declined today were: Span-America Medical ( SPAN), down 12.8%, Vision-Sciences Inc (DE ( VSCI), down 10.1%, Synergetics USA ( SURG), down 8.6% and MiMedx Group ( MDXG), down 7.3%.

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $38.7 billion and is part of the health care sector. Shares are up 6.9% year to date as of the close of trading on Tuesday. Currently there are 11 analysts that rate Baxter International a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins, increase in stock price during the past year and notable return on equity. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated.

On the positive front, Fonar Corporation ( FONR), up 20.8%, Hansen Medical ( HNSN), up 15.1%, Edap TMS ( EDAP), up 11.6% and Mazor Robotics ( MZOR), up 7.0% , were all gainers within the health services industry with HCA Holdings ( HCA) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Striking Options: Earnings, Gold, & Nasdaq

Striking Options: Earnings, Gold, & Nasdaq

Dow Surges More Than 540 Points on Strong Bank Earnings; Nasdaq Gains 2.9%

Dow Surges More Than 540 Points on Strong Bank Earnings; Nasdaq Gains 2.9%

The Next Oil Boom: Excitement About Alaskan Crude Builds

The Next Oil Boom: Excitement About Alaskan Crude Builds

Citi Tops Trading Rivals as JPMorgan, Bank of America Falter

Citi Tops Trading Rivals as JPMorgan, Bank of America Falter

Would a Porsche IPO Price Double Like Ferrari's Did?

Would a Porsche IPO Price Double Like Ferrari's Did?